|Institutional Source||Beutler Lab|
|Gene Name||dihydropyrimidine dehydrogenase|
|Is this an essential gene?||Possibly non essential (E-score: 0.368)|
|Stock #||R4066 (G1)|
|Chromosomal Location||118562129-119432918 bp(+) (GRCm38)|
|Type of Mutation||critical splice acceptor site|
|DNA Base Change (assembly)||AAT to AATGTATATATAT at 118897089 bp|
|Amino Acid Change|
|Ref Sequence||ENSEMBL: ENSMUSP00000039429 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000039177]|
|Predicted Effect||probably benign
|Predicted Effect||noncoding transcript
|Coding Region Coverage||
|Validation Efficiency||96% (50/52)|
|MGI Phenotype||FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene is a pyrimidine catabolic enzyme and the initial and rate-limiting factor in the pathway of uracil and thymidine catabolism. Mutations in this gene result in dihydropyrimidine dehydrogenase deficiency, an error in pyrimidine metabolism associated with thymine-uraciluria and an increased risk of toxicity in cancer patients receiving 5-fluorouracil chemotherapy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009]|
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Dpyd||
(F):5'- GAGATCTGTTAGATTGTTCAGAGC -3'
(R):5'- CCAGATAAGCTATGAATGATGTCTTAC -3'
(F):5'- CAGCTTGAATCTGTGGAAGCC -3'
(R):5'- CTGCTTTTGGCGACAAGT -3'
|Posted On||Dec 11, 2015|